Cargando…
Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288781/ http://dx.doi.org/10.1186/2051-1426-2-S3-P95 |
| _version_ | 1782352022477996032 |
|---|---|
| author | Bolaños-Mateo, Elixabet Weigelin, Bettina Teijeira, Alvaro Martinez-Forero, Ivan Labiano, Sara Azpilicueta, Arantza Morales-Kastresana, Aizea Quetglas, Jose I Wagena, Esther Rodriguez, Alfonso Chen, Lieping Friedl, Peter Melero, Ignacio |
| author_facet | Bolaños-Mateo, Elixabet Weigelin, Bettina Teijeira, Alvaro Martinez-Forero, Ivan Labiano, Sara Azpilicueta, Arantza Morales-Kastresana, Aizea Quetglas, Jose I Wagena, Esther Rodriguez, Alfonso Chen, Lieping Friedl, Peter Melero, Ignacio |
| author_sort | Bolaños-Mateo, Elixabet |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4288781 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42887812015-01-15 Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb Bolaños-Mateo, Elixabet Weigelin, Bettina Teijeira, Alvaro Martinez-Forero, Ivan Labiano, Sara Azpilicueta, Arantza Morales-Kastresana, Aizea Quetglas, Jose I Wagena, Esther Rodriguez, Alfonso Chen, Lieping Friedl, Peter Melero, Ignacio J Immunother Cancer Poster Presentation BioMed Central 2014-11-06 /pmc/articles/PMC4288781/ http://dx.doi.org/10.1186/2051-1426-2-S3-P95 Text en Copyright © 2014 Bolaños-Mateo et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Poster Presentation Bolaños-Mateo, Elixabet Weigelin, Bettina Teijeira, Alvaro Martinez-Forero, Ivan Labiano, Sara Azpilicueta, Arantza Morales-Kastresana, Aizea Quetglas, Jose I Wagena, Esther Rodriguez, Alfonso Chen, Lieping Friedl, Peter Melero, Ignacio Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb |
| title | Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb |
| title_full | Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb |
| title_fullStr | Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb |
| title_full_unstemmed | Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb |
| title_short | Focusing and sustaining the antitumor CTL effector killer response by agonist anti-CD137 mAb |
| title_sort | focusing and sustaining the antitumor ctl effector killer response by agonist anti-cd137 mab |
| topic | Poster Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288781/ http://dx.doi.org/10.1186/2051-1426-2-S3-P95 |
| work_keys_str_mv | AT bolanosmateoelixabet focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT weigelinbettina focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT teijeiraalvaro focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT martinezforeroivan focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT labianosara focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT azpilicuetaarantza focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT moraleskastresanaaizea focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT quetglasjosei focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT wagenaesther focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT rodriguezalfonso focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT chenlieping focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT friedlpeter focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab AT meleroignacio focusingandsustainingtheantitumorctleffectorkillerresponsebyagonistanticd137mab |